NGNE Next Earnings Date Notes

— Neurogene (NGNE) is a clinical-stage biotechnology company focused on developing genetic medicines for severe neurological diseases, with an emphasis on gene therapy platforms targeting rare pediatric disorders such as CLN7 Batten disease. Neurogene employs both in vivo and ex vivo gene therapy approaches, seeking to deliver lasting treatment effects by addressing underlying genetic causes. As you prepare for the upcoming earnings call, it is especially important to focus on updates to Neurogene’s clinical trial progress, particularly milestones for lead programs like NGN-401, as these represent critical value drivers. Key metrics to follow include enrollment rates, safety and efficacy data readouts, cash runway, R&D expense trends, and any partnerships or licensing deals that may bolster funding or provide validation for their technologies. Since Neurogene is pre-revenue, pipeline advancements, regulatory interactions & clear timelines toward pivotal trials or potential approvals are central to understanding future prospects. Listening for management commentary on upcoming catalysts, manufacturing readiness, and engagement with patient advocacy groups can also offer insight into the company’s ability to deliver on its mission and achieve long-term success. The next projected earnings date for NGNE is 3/27/2026 after close (stay tuned for a confirmed earnings date once announced).

NGNE Next Earnings Date FAQ

On this page we presented the NGNE Next Earnings Date information for Neurogene along with recent past earnings dates. For Q3 of 2025, NGNE reported earnings of -0.990/share, with the earnings report taking place on 11/13/2025. For Q2 of 2025, NGNE reported earnings of -1.050/share, with the earnings report taking place on 8/11/2025. For Q1 of 2025, NGNE reported earnings of -1.080/share, with the earnings report taking place on 5/9/2025. For Q4 of 2024, NGNE reported earnings of -1.000/share, with the earnings report taking place on 3/24/2025. For Q3 of 2024, NGNE reported earnings of -1.190/share, with the earnings report taking place on 11/18/2024. Based on these past earnings dates, the projected next earnings date for NGNE is 3/27/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Neurogene. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Neurogene shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Neurogene next earnings dates as well as any other stock out there in our coverage universe, to see when the next NGNE earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up NGNE's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the NGNE next earnings date.